Deletion of chromosome 1 predicts prognosis in pancreatic endocrine tumors

Cancer Research

Volumn 59, Issue 2, 1999, Pages 311-315

  Ebrahimi, Sam A ^a   Wang, Eric H ^a   Wu, Alan ^a   Schreck, Rhona R ^a   Passaro Jr , Edward ^a   Sawicki, Mark P ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Department of Surgery ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICROSATELLITE DNA;

ARTICLE; CARCINOGENESIS; CHROMOSOME 1; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; ENDOCRINE TUMOR; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; METASTASIS; MULTIPLE ENDOCRINE NEOPLASIA; PANCREAS TUMOR; PRIORITY JOURNAL; PROGNOSIS; TUMOR SUPPRESSOR GENE;

CHROMOSOMES, HUMAN, PAIR 1; GENES, TUMOR SUPPRESSOR; HUMANS; LOSS OF HETEROZYGOSITY; PANCREATIC NEOPLASMS; PROGNOSIS;

EID: 0033555995     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Howard, T. J., Stabile, B. E., Zinner, M. J., Chang, S., Bhagavan, B. S., and Passaro, E. J. Anatomic distribution of pancreatic endocrine tumors. Am. J. Surg., 159: 258-264, 1990.
2. Thompson, N. W. The surgical management of hyperparathyroidism and endocrine disease of the pancreas in the multiple endocrine neoplasia type 1 patient. J. Intern. Med., 238: 269-280, 1995.
3. Stabile, B. E., and Passaro, E. Benign and malignant gastrinomas. Am. J. Surg., 149: 144-150, 1985.
4. Weber, H. C., Venzon, D. J., Lin, J. T., Fishbein, V. A., Orhuch, M., Strader, D. B., Gibril, F., Metz, D. C., Fraker, D. L., and Norton, J. A. Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study. Gastroenterology, 108: 1637-1649, 1995.
5. Howard, T. J., Sawicki, M. P., Stabile, B. E., Watt, P. C., and Passaro, E. J. Biologic behavior of sporadic gastrinoma located to the right and left of the superior mesenteric artery. Am. J. Surg., 165: 101-105, 1993.
6. MacGillivray, D. C., Rushin, J. M., Zeiger, M. A., and Shakir, K. M. M. The significance of gastrinomas found in peripancreatic lymph nodes. Surgery (St. Louis), 109: 558-562, 1991.
7. Kahn, H. and Waxman, J. Peripancreatic lymph node gastrinoma in a patient with Zollinger-Ellison syndrome. Mt. Sinai J. Med., 59: 425-428, 1992.
8. Arnold, W. S., Fraker, D. L., Alexander, H. R., Weber, H. C., Norton, J. A., and Jensen, R. T. Apparent lymph node primary gastrinoma. Surgery (St. Louis), 116: 1123-1129, 1994.
9. Passaro, E. J., Howard, T. J., Sawicki, M. P., Watt, P. C. and Stabile, B. E. The origin of sporadic gastrinomas within the gastrinoma triangle: a theory. Arch. Surg., 133: 13-16, 1998.
10. Schwab, M., Praml, C., and Amler, L. C. Genomic instability in Ip and human malignancies. Genes Chromosomes Cancer (Phila.), 16: 211-229, 1996.
11. Cryns, V. L., Yi, S. M., Tahara, H., Gaz, R. D., and Arnold, A. Frequent loss of chromosome arm 1p DNA in parathyroid adenomas. Genes Chromosomes Cancer, 13: 9-17, 1995.
12. Williamson, C., Pannett, A. A., Pang, J. T., Wooding, C., McCarthy, M., Sheppard, M. N., Monson, J., Clayton, R. N., and Thakker, R. V. Localisation of a gene causing endocrine neoplasia to a 4 cM region on chromosome 1p35-p36. J. Med. Genet., 34: 617-619, 1997.
13. Mulligan, L. M., Gardner, E., Smith, B. A., Mathew, C. G., and Ponder, B. A. Genetic events in tumour initiation and progression in multiple endocrine neoplasia type 2. Genes Chromosomes Cancer, 6: 166-177, 1993.
14. Yokogoshi, Y., Yoshimoto, K., and Saito, S. Loss of heterozygosity on chromosomes 1 and 11 in sporadic pheochromocytomas. Jpn. J. Cancer Res., 81: 632-638, 1990.
15. Tsutsumi, M., Yokota, J., Kakizoe, T., Koiso, K., Sugimura, T., and Terada, M. Loss of heterozygosity on chromosomes 1p and 11p in sporadic pheochromocytoma. J. Natl. Cancer Inst., 81: 367-370, 1989.
16. Moley, J. F., Brother, M. B., Fong, C. T., White, P. S., Baylin, S. B., Nelkin, B., Wells, S. A., and Brodeur, G. M. Consistent association of 1p loss of heterozygosity with pheochromocytomas from patients with multiple endocrine neoplasia type 2 syndromes. Cancer Res., 52: 770-774, 1992.
17. Bystrom, C., Larsson, C., Blomberg, C., Sandelin, K., Falkmer, U., Skogseid, B., Oberg, K., Wemer, S., and Nordenskjold, M. Localization of the MEN1 gene to a small region within chromosome 11q13 by deletion mapping in tumors. Proc. Natl. Acad. Sci. USA, 87: 1968-1972, 1990.
18. Chung, D. C., Smith, A. P., Louis, D. N., Graeme-Cook, F., Warshaw, A. L., and Arnold, A. A novel pancreatic endocrine tumor suppressor gene locus on chromosome 3p with clinical prognostic implications. J. Clin. Invest., 100: 404-410, 1997.
19. Kaghad, M., Bonnet, H., Yang, A., Creancier, L., Biscan, J. C., Valent, A., Minty, A., Chalon, P., Lelias, J. M., Dumont, X., Ferrara, P., McKeon, F., and Caput, D. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell, 90: 809-819, 1997.
20. Caron, H., van Sluis, P., de Kraker, J., Bokkerink, J., Egeler, M., Laureys, G., Slater, R., Westerveld, A., Voute, P. A., and Versteeg, R. Allelic loss of chromosome Ip as a predictor of unfavorable outcome in patients with neuroblastoma. N. Engl. J. Med., 334: 225-230, 1996.
21. Teh, B. T., Farnebo, F., Kristoffersson, U., Sundelin, B., Cardinal, J., Axelson, R., Yap, A., Epstein, M., Heath, H., Cameron, D., and Larsson, C. Autosomal dominant primary hyperparathyroidism and jaw tumor syndrome associated with renal hamartomas and cystic kidney disease: linkage to 1q21-q32 and loss of the wild type allele in renal hamartomas. J. Clin. Endocrinol. Metab., 81: 4204-4211, 1996.
22. Howard, T. J., Zinner, M. J., Stabile, B. E., and Passaro, E. Gastrinoma excision for cure: prospective analysis. Ann. Surg., 211: 9-14, 1990.